Transcat Inc
NASDAQ:TRNS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (24.9), the stock would be worth $100.93 (26% upside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 19.7 | $80.11 |
0%
|
| 3-Year Average | 24.9 | $100.93 |
+26%
|
| 5-Year Average | 23.9 | $97.08 |
+21%
|
| Industry Average | 13 | $52.86 |
-34%
|
| Country Average | 14.4 | $58.26 |
-27%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
$840.1m
|
/ |
Dec 2025
$42.8m
|
= |
|
|
$840.1m
|
/ |
Mar 2026
$48.6m
|
= |
|
|
$840.1m
|
/ |
Mar 2027
$54.3m
|
= |
|
|
$840.1m
|
/ |
Mar 2028
$53.4m
|
= |
|
|
$840.1m
|
/ |
Mar 2029
$63.9m
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Transcat Inc
NASDAQ:TRNS
|
747.5m USD | 19.7 | 94.7 | |
| JP |
|
Mitsubishi Corp
TSE:8058
|
18.4T JPY | 26.7 | 25.1 | |
| JP |
|
Mitsui & Co Ltd
TSE:8031
|
16.6T JPY | 23.9 | 19.3 | |
| JP |
|
Itochu Corp
TSE:8001
|
15.7T JPY | 16.2 | 16.9 | |
| JP |
|
Marubeni Corp
TSE:8002
|
9.6T JPY | 23 | 18.8 | |
| US |
W
|
WW Grainger Inc
XMUN:GWW
|
46B EUR | 20.2 | 31.5 | |
| US |
|
W W Grainger Inc
NYSE:GWW
|
55.1B USD | 20.6 | 32.3 | |
| US |
|
Fastenal Co
NASDAQ:FAST
|
52.6B USD | 27.7 | 40.4 | |
| US |
|
Ferguson Enterprises Inc
NYSE:FERG
|
50.8B USD | 43.1 | 64.6 | |
| US |
|
United Rentals Inc
NYSE:URI
|
50.2B USD | 8.8 | 20.1 | |
| JP |
|
Sumitomo Corp
TSE:8053
|
7.2T JPY | 15.2 | 13 |
Market Distribution
| Min | 0 |
| 30th Percentile | 10 |
| Median | 14.4 |
| 70th Percentile | 21.5 |
| Max | 1 767 274.1 |
Other Multiples
Transcat Inc
Glance View
Transcat, Inc. engages in provision of calibration and laboratory instrument services. The company is headquartered in Rochester, New York and currently employs 765 full-time employees. Transcat is focused on providing services and products to the life science industry, which includes pharmaceutical, biotechnology, medical device, and other FDA-regulated businesses. Transcat operates through two segments: Service and Distribution. Its Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting, and other related services. Its distribution segment it sells and rent national and brand instruments to customers globally. Its other industries served includes industrial manufacturing; energy and utilities, including oil and gas; chemical manufacturing; FAA-regulated businesses, including aerospace and defense and other industries.
